Fuelling Innovation through Strategic Funding
ACCELERATOR
N-Series: Technology Development
Active Calls
No active calls at this time.
A-Series: Novel Therapeutic Target
Active Calls
No active calls at this time.
T-Series: Strategic Industry Partnerships
Active Calls
T02
Research Collaboration with industry
Submission Deadline: 30 Sept 2025
Maximum Duration: 3 years
Maximum Quantum: S$5,000,000 (including 30% indirect costs)
Have an idea? Email Us!
Have other Nucleic Acid Therapeutics drug development project idea?
Arrange for a discussion for ad-hoc funding!